Pre-order Enquiry
Request Free Sample
Global Mineral-based Adjuvants Market Research Report 2022
SKU ID : QYR-21496037 | Publishing Date : 17-Aug-2022
Request Sample
Request Customization
Check Discounts
An adjuvant is a substance which is added to a vaccine with the aim of increasing the efficiency of that vaccine.
From a chemical point of view, adjuvants are a highly heterogeneous group of compounds that share only one functional characteristic: that of being able to enhance immune responses.
Adjuvants are used in vaccine production to stimulate the immune system and raise an early, long-lasting and efficient immune response to the vaccine. This increases efficacy and provides a high degree of protection from the disease against which you are vaccinating. By using adjuvants you will reach the same level of immune protection using fewer injections than when vaccinating with the non-adjuvanted antigen.
This report focuses on Mineral-based Adjuvants market.
Due to the COVID-19 pandemic, the global Mineral-based Adjuvants market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Mineral-based Adjuvants market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Mineral-based Adjuvants landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Aluminum Compounds accounting for % of the Mineral-based Adjuvants global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Human Vaccines segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Mineral-based Adjuvants include Thermol Fisher, Croda (Brenntag Biosector), Creative Biolabs, SPI Pharma, Chemtrade and Creative Diagnostics, etc. In terms of revenue, the global 3 largest players have a % market share of Mineral-based Adjuvants in 2021.
This report focuses on Mineral-based Adjuvants volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mineral-based Adjuvants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Mineral-based Adjuvants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Aluminum Compounds
Calcium Phosphate Adjuvants
Segment by Application
Human Vaccines
Veterinary Vaccines
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Thermol Fisher
Croda (Brenntag Biosector)
Creative Biolabs
SPI Pharma
Chemtrade
Creative Diagnostics
From a chemical point of view, adjuvants are a highly heterogeneous group of compounds that share only one functional characteristic: that of being able to enhance immune responses.
Adjuvants are used in vaccine production to stimulate the immune system and raise an early, long-lasting and efficient immune response to the vaccine. This increases efficacy and provides a high degree of protection from the disease against which you are vaccinating. By using adjuvants you will reach the same level of immune protection using fewer injections than when vaccinating with the non-adjuvanted antigen.
This report focuses on Mineral-based Adjuvants market.
Due to the COVID-19 pandemic, the global Mineral-based Adjuvants market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Mineral-based Adjuvants market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Mineral-based Adjuvants landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Aluminum Compounds accounting for % of the Mineral-based Adjuvants global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Human Vaccines segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Mineral-based Adjuvants include Thermol Fisher, Croda (Brenntag Biosector), Creative Biolabs, SPI Pharma, Chemtrade and Creative Diagnostics, etc. In terms of revenue, the global 3 largest players have a % market share of Mineral-based Adjuvants in 2021.
This report focuses on Mineral-based Adjuvants volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mineral-based Adjuvants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Mineral-based Adjuvants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Aluminum Compounds
Calcium Phosphate Adjuvants
Segment by Application
Human Vaccines
Veterinary Vaccines
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Thermol Fisher
Croda (Brenntag Biosector)
Creative Biolabs
SPI Pharma
Chemtrade
Creative Diagnostics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
